We have been awarded the ISO 9001:2015 certificate in Research and Development of In-vitro Diagnostics Medical Devices.

You could meet us once again at the EIC Accelerator Awareness Event for Czech Republic and Slovakia, which took place in Brno, Czech Republic, on 11 July 2022. Our CEO

Tests developed by the innovative Slovak company Glycanostics bring hope and solutions for the early non-invasive diagnosis of prostate cancer and 10 other types of cancer. With an accuracy of

Our CEO Eva Kovacova presented Glycanostic’s success story as well as learnings and experience with the EIC Accelerator scheme during the EU Finance Day for Businesses organized by the European